Cargando…
Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J
BACKGROUND: Cisplatin (DDP)-based chemotherapy is the common first-line therapy for lung cancer. However, their efficacy is often limited by primary drug resistance and/or acquired drug resistance. The aim of this study was to investigate the function of miRNA-146a (miR-146a) in DDP-resistant non-sm...
Autores principales: | Shi, Lin, Xu, Zhaozhong, Wu, Gang, Chen, Xiaoting, Huang, Yuanyuan, Wang, Yanjing, Jiang, Weiqiang, Ke, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312565/ https://www.ncbi.nlm.nih.gov/pubmed/28202053 http://dx.doi.org/10.1186/s12885-017-3132-9 |
Ejemplares similares
-
miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma
por: Qiu, Zhenwei, et al.
Publicado: (2017) -
Downregulation of miR-146a inhibits osteoporosis in the jaws of ovariectomized rats by regulating the Wnt/β-catenin signaling pathway
por: Liu, Hua, et al.
Publicado: (2021) -
miR-146a regulates insulin sensitivity via NPR3
por: Roos, Julian, et al.
Publicado: (2020) -
Downregulation of miR-146a Contributes to Cardiac Dysfunction Induced by the Tyrosine Kinase Inhibitor Sunitinib
por: Shen, Li, et al.
Publicado: (2019) -
Cisplatin sensitivity and thermochemosensitisation in thermotolerant cDDP-sensitive and -resistant cell lines.
por: Hettinga, J. V., et al.
Publicado: (1995)